These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 11446315)
1. [The value of qualitative regression grading as a prognostic factor for survival after preoperative radiochemotherapy in patients with advanced head and neck cancer]. Hermann RM; Krech R; Hartlapp J; Esser E; Christoph B; Müller MK; Wagner W Strahlenther Onkol; 2001 Jun; 177(6):277-82. PubMed ID: 11446315 [TBL] [Abstract][Full Text] [Related]
2. Impact of tumor control and presence of visible necrosis in head and neck cancer patients treated with radiotherapy or radiochemotherapy. Kuhnt T; Mueller AC; Pelz T; Haensgen G; Bloching M; Koesling S; Schubert J; Dunst J J Cancer Res Clin Oncol; 2005 Nov; 131(11):758-64. PubMed ID: 16088405 [TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of two dosages and schedules of ifosfamide in combination with cisplatin in neo-adjuvant chemotherapy of patients with advanced (stage III-IV) head and neck squamous cell carcinoma: a phase II randomized study. Mantovani G; Ghiani M; Lai P; Maccio A; Dessi D; Succu G; Massa D; Curreli L; Mulas C; Esu S; Proto E; Cadeddu G; Tore G Oncol Rep; 1998; 5(6):1499-505. PubMed ID: 9769395 [TBL] [Abstract][Full Text] [Related]
4. Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancer. Wanebo HJ; Glicksman AS; Landman C; Slotman G; Doolittle C; Clark J; Koness RJ Am J Surg; 1995 Nov; 170(5):512-6. PubMed ID: 7485745 [TBL] [Abstract][Full Text] [Related]
5. [Accelerated hyperfractionated simultaneous radiochemotherapy in advanced head-neck carcinomas in comparison: split course and concomitant boost concept]. Dietz A; Rudat V; Nollert J; Flentje M; Maiei H; Wannenmacher M; Weidauer H Laryngorhinootologie; 1996 Dec; 75(12):745-53. PubMed ID: 9081280 [TBL] [Abstract][Full Text] [Related]
6. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis. Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864 [TBL] [Abstract][Full Text] [Related]
7. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up. Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029 [TBL] [Abstract][Full Text] [Related]
8. Dose-finding study of docetaxel added to ifosfamide and cisplatin followed by concomitant capecitabine and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck. Recchia F; Saggio G; Cesta A; Amiconi G; di Blasio A; Candeloro G; Valeriani M; Tombolini V; Rea S Anticancer Res; 2006; 26(3B):2317-24. PubMed ID: 16821609 [TBL] [Abstract][Full Text] [Related]
9. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study. Leyvraz S; Pasche P; Bauer J; Bernasconi S; Monnier P J Clin Oncol; 1994 Sep; 12(9):1876-85. PubMed ID: 8083711 [TBL] [Abstract][Full Text] [Related]
10. Phase II trial of cisplatin, 5-fluorouracil and folinic acid using a weekly 24-h infusion schedule for locally advanced head and neck cancer: a pharmacokinetic and clinical survey. Riva C; Lavieille JP; Schmerber S; Cuisnie O; Reyt E Int J Oncol; 2000 Sep; 17(3):543-9. PubMed ID: 10938396 [TBL] [Abstract][Full Text] [Related]
11. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. Merlano M; Benasso M; Corvò R; Rosso R; Vitale V; Blengio F; Numico G; Margarino G; Bonelli L; Santi L J Natl Cancer Inst; 1996 May; 88(9):583-9. PubMed ID: 8609658 [TBL] [Abstract][Full Text] [Related]
12. Phase I trial of retinoic acid and cis-platinum for advanced squamous cell cancer of the head and neck based on experimental evidence of drug synergism. Weisman RA; Christen R; Los G; Jones V; Kerber C; Seagren S; Glassmeyer S; Orloff LA; Wong W; Kirmani S; Howell S Otolaryngol Head Neck Surg; 1998 May; 118(5):597-602. PubMed ID: 9591856 [TBL] [Abstract][Full Text] [Related]
13. Hyperfractionated radiation therapy and concurrent 5-fluorouracil, cisplatin and mitomycin-C in head and neck carcinoma. A pilot study. Abitbol AA; Schwade JG; Lewin AA; Sridhar K; Brandon AH; Markoe AM; Casiano RR; Houdek PV; Serago C; Miller DJ Am J Clin Oncol; 1992 Jun; 15(3):250-5. PubMed ID: 1590280 [TBL] [Abstract][Full Text] [Related]
14. An original accelerated radiotherapy schedule in stage III to IV head and neck cancers. Results in a multicenter setting. Allal AS; Monney M; Rosset A; Ozsahin M; Guillemin C Strahlenther Onkol; 2000 Jan; 176(1):28-31. PubMed ID: 10650833 [TBL] [Abstract][Full Text] [Related]
15. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo. Paccagnella A; Orlando A; Marchiori C; Zorat PL; Cavaniglia G; Sileni VC; Jirillo A; Tomio L; Fila G; Fede A J Natl Cancer Inst; 1994 Feb; 86(4):265-72. PubMed ID: 8158680 [TBL] [Abstract][Full Text] [Related]
16. Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracil. Wibault P; Bensmaine MA; de Forni M; Armand JP; Tellez Bernal E; Guillot T; Recondo G; Domenge C; Janot F; Borel C; Luboinski B; Eschwege F; Cvitkovic E J Clin Oncol; 1996 Apr; 14(4):1192-200. PubMed ID: 8648374 [TBL] [Abstract][Full Text] [Related]
17. Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck. Tsao AS; Garden AS; Kies MS; Morrison W; Feng L; Lee JJ; Khuri F; Zinner R; Myers J; Papadimitrakopoulou V; Lewin J; Clayman GL; Ang KK; Glisson BS J Clin Oncol; 2006 Sep; 24(25):4163-9. PubMed ID: 16943532 [TBL] [Abstract][Full Text] [Related]
18. Concomitant administration of two standard regimens of chemotherapy and radiotherapy in advanced squamous carcinoma of the head and neck: a feasibility study. Benasso M; Corvò R; Numico G; Cavallari M; Blengio F; Sanguineti G; Rosso M; Merlano M Anticancer Res; 1995; 15(6B):2651-4. PubMed ID: 8669841 [TBL] [Abstract][Full Text] [Related]
19. Concomitant cisplatin, paclitaxel, and hyperfractionated radiotherapy in locally advanced head and neck cancer: comparison of two different schedules. Moreno-Jiménez M; Valero J; López-Picazo JM; Arbea L; Aristu J; Cambeiro M; Alcalde J; Martínez-Monge R Am J Clin Oncol; 2010 Apr; 33(2):137-43. PubMed ID: 19786847 [TBL] [Abstract][Full Text] [Related]
20. A phase I trial of weekly docetaxel and cisplatinum combined to concurrent hyperfractionated radiotherapy for non-small cell lung cancer and squamous cell carcinoma of head and neck. Varveris H; Mazonakis M; Vlachaki M; Kachris S; Lyraraki E; Zoras O; Maris T; Froudarakis M; Velegrakis J; Perysinakis C; Damilakis J; Samonis G Oncol Rep; 2003; 10(1):185-95. PubMed ID: 12469168 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]